The forward P/E ratio, which uses projected earnings for the next financial year, is 26.3. Additionally, the Price-to-Sales Ratio is 2.37, reflecting the market’s valuation of the company’s sales, ...
On Friday, Syndax Pharmaceuticals Inc (SNDX) stock saw a decline, ending the day at $19.71 which represents a decrease of $-0.18 or -0.90% from the prior close of $19.89. The stock opened at $19.92 ...